Bheemanathi Hanuman Srinivas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bheemanathi Hanuman Srinivas has a total of 154 co-authors. Here are the top co-authors by number of shared publications:
- Debasis Gochhait
Department of Pathology Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) Puducherry India
4 shared publications - Rajesh Nachiappa Ganesh
Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
4 shared publications Debasis Gochhait
Department of Pathology, JIPMER, Puducherry, India
3 shared publicationsPs Priyamvada
Department of Nephrology, JIPMER, Puducherry, India
3 shared publicationsRajesh Nachiappa Ganesh
Department of Pathology, JIPMER, Puducherry, India
3 shared publications- Sreerekha Jinkala
Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
3 shared publications
Latest Publications
- 9 September 2026
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
Topical Tofacitinib in the Treatment of Lichenoid Pseudovesicular Papular Eruptions of the Nose
Was not provided for this article.
- 9 September 2026
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
Topical Tofacitinib in the Treatment of Lichenoid Pseudovesicular Papular Eruptions of the Nose
Was not provided for this article.
- Open Access
- 7 July 2025
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 28  (4) , 606-608
Cerebral Chromoblastomycosis: A Unique Presentation of Dematiaceous Fungal Infection in an Immunocompromised Patient
An abstract is unavailable. This article is available as a PDF only.
- 7 July 2025
- Published by Wolters Kluwer Health in Annals of Indian Academy of Neurology
- Vol. 28  (4) , 606-608
Open AccessCerebral Chromoblastomycosis: A Unique Presentation of Dematiaceous Fungal Infection in an Immunocompromised Patient
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in Indian Journal of Ophthalmology - Case Reports
- Vol. 5  (3) , 393-395
Mucinous carcinoma in orbit – primary or secondary? A diagnostic dilemma. A case report and review of the literature
Metastatic orbital tumors are rare. Herein, we present a case of mucinous carcinoma of the breast with metastasis to the orbit as the presenting feature. It is challenging to distinguish between primary mucinous carcinoma arising in the orbit and metastatic mucinous carcinoma. Both of them have similar histopathology as well as immunohistochemical profile. Accurate pathological diagnosis based on subtle histopathologic differences, immunohistochemical panel, and clinico-radiological correlation is crucial to distinguish between primary and secondary and to pinpoint the exact primary site when it is metastatic.
- 1 July 2025
- Published by Wolters Kluwer Health in Indian Journal of Ophthalmology - Case Reports
- Vol. 5  (3) , 393-395
Open AccessMucinous carcinoma in orbit – primary or secondary? A diagnostic dilemma. A case report and review of the literature
Metastatic orbital tumors are rare. Herein, we present a case of mucinous carcinoma of the breast with metastasis to the orbit as the presenting feature. It is challenging to distinguish between primary mucinous carcinoma arising in the orbit and metastatic mucinous carcinoma. Both of them have similar histopathology as well as immunohistochemical profile. Accurate pathological diagnosis based on subtle histopathologic differences, immunohistochemical panel, and clinico-radiological correlation is crucial to distinguish between primary and secondary and to pinpoint the exact primary site when it is metastatic.
- Open Access
- 25 April 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12  (5) , e01683
Isolated Metachronous Intraluminal Colonic Metastasis in Carcinoma Gall Bladder: The Path Less Trodden
Gallbladder cancer (GBC) is characterized by late presentation, early systemic spread, and poor long-term survival. A 65-year-old woman presented with isolated intraluminal colonic metastasis 46 months after radical surgery for GBC. The patient also underwent subtotal cholecystectomy 12 years before the diagnosis of GBC. In view of gastrointestinal bleeding, the patient underwent laparoscopic transverse colectomy with colocolic anastomosis. Metachronous isolated intraluminal colonic metastasis is being reported for the first time in English literature. The possible routes of colonic metastasis and its optimum management in the metachronous setting are discussed in this report.
- 25 April 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12  (5) , e01683
Open AccessIsolated Metachronous Intraluminal Colonic Metastasis in Carcinoma Gall Bladder: The Path Less Trodden
Gallbladder cancer (GBC) is characterized by late presentation, early systemic spread, and poor long-term survival. A 65-year-old woman presented with isolated intraluminal colonic metastasis 46 months after radical surgery for GBC. The patient also underwent subtotal cholecystectomy 12 years before the diagnosis of GBC. In view of gastrointestinal bleeding, the patient underwent laparoscopic transverse colectomy with colocolic anastomosis. Metachronous isolated intraluminal colonic metastasis is being reported for the first time in English literature. The possible routes of colonic metastasis and its optimum management in the metachronous setting are discussed in this report.
- 28 March 2025
- Published by Springer Nature in Child's Nervous System
- Vol. 41  (1) , 1-7
Giant calvarial metastasis from secondary Ewing sarcoma with chronic subdural hygroma in a childhood hematological cancer survivor — An unusual case report
We report an unusual case of a 9-year-old boy with Hodgkin lymphoma post chemoradiotherapy, who later developed Ewing sarcoma involving the eighth rib, which had metastasised to the cranial vault with meningeal and subdural involvement. Presenting with seizures, headache and hemiparesis, he underwent craniotomy and gross total tumour resection, with histopathology confirming metastatic Ewing sarcoma. Despite initial improvement, the patient presented with further cranial metastasis on follow-up. This case contributes to the limited literature on Ewing sarcoma metastasis to the CNS in patients with prior hematologic malignancies, questioning potential links between therapeutic chemoradiotherapy exposures and secondary cancer development. This case emphasises the unusual metachronous presentation of Hodgkin lymphoma and Ewing sarcoma and the high risk of recurrence and CNS involvement in cranial Ewing sarcoma, highlighting challenges in management and prognosis.
- 28 March 2025
- Published by Springer Nature in Child's Nervous System
- Vol. 41  (1) , 1-7
Giant calvarial metastasis from secondary Ewing sarcoma with chronic subdural hygroma in a childhood hematological cancer survivor — An unusual case report
We report an unusual case of a 9-year-old boy with Hodgkin lymphoma post chemoradiotherapy, who later developed Ewing sarcoma involving the eighth rib, which had metastasised to the cranial vault with meningeal and subdural involvement. Presenting with seizures, headache and hemiparesis, he underwent craniotomy and gross total tumour resection, with histopathology confirming metastatic Ewing sarcoma. Despite initial improvement, the patient presented with further cranial metastasis on follow-up. This case contributes to the limited literature on Ewing sarcoma metastasis to the CNS in patients with prior hematologic malignancies, questioning potential links between therapeutic chemoradiotherapy exposures and secondary cancer development. This case emphasises the unusual metachronous presentation of Hodgkin lymphoma and Ewing sarcoma and the high risk of recurrence and CNS involvement in cranial Ewing sarcoma, highlighting challenges in management and prognosis.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in International Journal of Advanced Medical and Health Research
- Vol. 12  (1) , 50-52
Pigmented Variant of Dermatofibrosarcoma Protuberans (Bednar Tumor) Masquerading as Vascular Lesion on Imaging
A pigmented variant of dermatofibrosarcoma protuberans (DFSP) is a rare variant with intermediate-grade potential and has the propensity for local recurrence. It is essential to understand the morphology of this tumor, and it needs to be differentiated from other pigmented lesions of the skin. It is unusual for this tumor to present as a vascular lesion on radiological investigation. Here, we report the case of a 38-year-old male with a thigh mass and imaging features suggestive of vascular malformation. He was diagnosed with a pigmented variant of dermatofibrosarcoma protuberans following histopathology of the excision biopsy specimen. We report this case due to the rarity of the entity and its masquerading as a vascular lesion on imaging.
- 1 January 2025
- Published by Wolters Kluwer Health in International Journal of Advanced Medical and Health Research
- Vol. 12  (1) , 50-52
Open AccessPigmented Variant of Dermatofibrosarcoma Protuberans (Bednar Tumor) Masquerading as Vascular Lesion on Imaging
A pigmented variant of dermatofibrosarcoma protuberans (DFSP) is a rare variant with intermediate-grade potential and has the propensity for local recurrence. It is essential to understand the morphology of this tumor, and it needs to be differentiated from other pigmented lesions of the skin. It is unusual for this tumor to present as a vascular lesion on radiological investigation. Here, we report the case of a 38-year-old male with a thigh mass and imaging features suggestive of vascular malformation. He was diagnosed with a pigmented variant of dermatofibrosarcoma protuberans following histopathology of the excision biopsy specimen. We report this case due to the rarity of the entity and its masquerading as a vascular lesion on imaging.
- Open Access
- 23 October 2024
- Published by Galenos Yayinevi in Turkish Archives of Otorhinolaryngology
- Vol. 62  (2) , 66-71
Management of Disseminated Rhinosporidiosis: Experience From a Single Tertiary Institution
Management of Disseminated Rhinosporidiosis: Experience From a Single Tertiary Institution - Turkish Archives of Otorhinolaryngology
- 23 October 2024
- Published by Galenos Yayinevi in Turkish Archives of Otorhinolaryngology
- Vol. 62  (2) , 66-71
Open AccessManagement of Disseminated Rhinosporidiosis: Experience From a Single Tertiary Institution
Management of Disseminated Rhinosporidiosis: Experience From a Single Tertiary Institution - Turkish Archives of Otorhinolaryngology
- Open Access
- 15 July 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Pathology and Oncology
- Vol. 11  (2) , 183-186
Incidental detection of intrahepatic cholangiocarcinoma in an explant liver: An unforeseen encounter
Incidental intrahepatic cholangiocarcinoma (i-ICCA) is an uncommonly encountered malignancy in an explant liver. The presence of i-ICCA in an explant liver indicates poor prognosis and high chances of recurrence. Therefore, histopathological diagnosis of i-ICCA in an explant liver specimen is crucial for the patient. In this case report, we present a case of i-ICCA diagnosed in an explant liver showing features of alcoholic cirrhosis with a brief discussion on its salient features and relevant differential diagnoses.
- 15 July 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Pathology and Oncology
- Vol. 11  (2) , 183-186
Open AccessIncidental detection of intrahepatic cholangiocarcinoma in an explant liver: An unforeseen encounter
Incidental intrahepatic cholangiocarcinoma (i-ICCA) is an uncommonly encountered malignancy in an explant liver. The presence of i-ICCA in an explant liver indicates poor prognosis and high chances of recurrence. Therefore, histopathological diagnosis of i-ICCA in an explant liver specimen is crucial for the patient. In this case report, we present a case of i-ICCA diagnosed in an explant liver showing features of alcoholic cirrhosis with a brief discussion on its salient features and relevant differential diagnoses.
- Open Access
- 1 July 2024
- Published by Wolters Kluwer Health in International Journal of Advanced Medical and Health Research
- Vol. 11  (2) , 129-131
Juvenile Xanthogranuloma: A Case Report and Literature Review of an Underdiagnosed Benign Entity
Juvenile xanthogranuloma (JXG) is an uncommon non-Langerhans cell histiocytic lesion that usually occurs at an early age and is asymptomatic. It is usually a self-limiting disorder, and predilection sites are the head and neck, extremities, and trunk. We report a 3-year-old male child who presented to the hospital with asymptomatic swelling in the right upper eyelid region. Excision biopsy was done, and histopathology along with immunohistochemistry was reported as JXG. It is essential to differentiate this condition from childhood malignancy.
- 1 July 2024
- Published by Wolters Kluwer Health in International Journal of Advanced Medical and Health Research
- Vol. 11  (2) , 129-131
Open AccessJuvenile Xanthogranuloma: A Case Report and Literature Review of an Underdiagnosed Benign Entity
Juvenile xanthogranuloma (JXG) is an uncommon non-Langerhans cell histiocytic lesion that usually occurs at an early age and is asymptomatic. It is usually a self-limiting disorder, and predilection sites are the head and neck, extremities, and trunk. We report a 3-year-old male child who presented to the hospital with asymptomatic swelling in the right upper eyelid region. Excision biopsy was done, and histopathology along with immunohistochemistry was reported as JXG. It is essential to differentiate this condition from childhood malignancy.
- Open Access
- 20 June 2024
- Published by Wolters Kluwer Health in Indian Journal of Pathology and Microbiology
- Vol. 68  (1) , 113-117
Myeloid sarcoma: Experience from a tertiary care center in southern India – A series of eight unusual cases
Background: Myeloid sarcoma (MS) is a tumor mass comprising myeloid blasts with or without maturation occurring in any site other than bone marrow. It is a rare and distinct clinical presentation of myeloid neoplasm. Materials and Methods: This is a retrospective study over 7 years (2015–2022) comprising a series of eight cases, which includes clinical details, morphology, immunohistochemistry (IHC) markers, cytogenetics, and molecular details. Results: These cases showed up as an isolated MS (3/8), as an initial clinical presentation in acute myeloid leukemia (1/8), as acute myeloid leukemia (1/8), as a disease progression in primary myelofibrosis (1/8), as chronic myeloid leukemia (1/8), and as BCR-ABL-negative myelodysplastic syndrome/myeloproliferative neoplasm (1/8). One of the three isolated MS was incorrectly identified as having Ewing’s sarcoma. One case each presented at the cervical lymph node, mediastinum, skin, sacral soft tissue, maxillary sinus, and perinephric fat, and two cases presented at the hard palate. Conclusion: Four of the cases in our study were clinically thought of as lymphoma/sarcoma, which was a major diagnostic challenge. All but one case succumbed to their disease. Without adequate clinical history and appropriate use of ancillary techniques such as IHC in tissue biopsies, flow cytometry, cytogenetics, and molecular studies, these cases have a high chance of being misdiagnosed as non-Hodgkin lymphoma, small round blue cell tumor, or undifferentiated carcinomas, which can complicate patient management and prognosis.
- 20 June 2024
- Published by Wolters Kluwer Health in Indian Journal of Pathology and Microbiology
- Vol. 68  (1) , 113-117
Open AccessMyeloid sarcoma: Experience from a tertiary care center in southern India – A series of eight unusual cases
Background: Myeloid sarcoma (MS) is a tumor mass comprising myeloid blasts with or without maturation occurring in any site other than bone marrow. It is a rare and distinct clinical presentation of myeloid neoplasm. Materials and Methods: This is a retrospective study over 7 years (2015–2022) comprising a series of eight cases, which includes clinical details, morphology, immunohistochemistry (IHC) markers, cytogenetics, and molecular details. Results: These cases showed up as an isolated MS (3/8), as an initial clinical presentation in acute myeloid leukemia (1/8), as acute myeloid leukemia (1/8), as a disease progression in primary myelofibrosis (1/8), as chronic myeloid leukemia (1/8), and as BCR-ABL-negative myelodysplastic syndrome/myeloproliferative neoplasm (1/8). One of the three isolated MS was incorrectly identified as having Ewing’s sarcoma. One case each presented at the cervical lymph node, mediastinum, skin, sacral soft tissue, maxillary sinus, and perinephric fat, and two cases presented at the hard palate. Conclusion: Four of the cases in our study were clinically thought of as lymphoma/sarcoma, which was a major diagnostic challenge. All but one case succumbed to their disease. Without adequate clinical history and appropriate use of ancillary techniques such as IHC in tissue biopsies, flow cytometry, cytogenetics, and molecular studies, these cases have a high chance of being misdiagnosed as non-Hodgkin lymphoma, small round blue cell tumor, or undifferentiated carcinomas, which can complicate patient management and prognosis.